Hepatitis B

Hepatitis B is one type of hepatitis – a liver disease- caused by the hepatitis B virus (HBV). Hepatitis B spreads by contact with an infected person's blood, semen or other body fluid. An infected woman can give hepatitis B to her baby at birth.

What is Hepatitis B?

Hepatitis B is a viral infection of the liver that is spread when contact is made with blood or blood products from an infected individual.

Hepatitis B Mechanisms

Hepatitis B Diagnosis

Hepatitis B Prevention

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

Ratiometric fluorescent probes for measuring active albumin in liver disease patients

Albumin is a major prognostic factor for patients with advanced liver disease, dependent on its concentration and biological activity.

29 Oct 2024

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

The effect of tenofovir amibufenamide (TMF) on blood lipid profiles in patients with chronic hepatitis B (CHB) remains unclear. This study aimed to explore whether TMF affects blood lipids during 48 weeks in patients with CHB.

26 Oct 2024

Evaluating the effectiveness of GAAD for early detection of hepatocellular carcinoma

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis.

25 Oct 2024

Cardiovascular risks of COVID-19 antivirals

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing these drugs to high-risk patients.

16 Sep 2024

Global and Local Efforts to Take Action Against Hepatitis

In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the Coalition for Global Hepatitis Elimination (CGHE), and James Amugsi, a Mandela Washington Fellow and Physician Assistant at Sandema Hospital in Ghana. Together, they provide valuable insights into the challenges, successes, and the importance of partnerships in the fight against hepatitis.

20 Aug 2024

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Researchers investigated the relationship between state COVID-19 vaccination mandates for healthcare workers and vaccination rates among them.

19 Aug 2024

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Routine childhood vaccinations among children born between 1994 and 2023 have prevented millions of illnesses and deaths in the U.S., saving $540 billion in direct costs and $2.7 trillion in societal costs.

12 Aug 2024

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Research paper reviews the efficacy of the first licensed malaria vaccines, RTS,S and R21, highlighting their potential to significantly reduce childhood mortality and discussing future vaccine development strategies.

21 Jul 2024

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective management and improved survival rates.

16 Jul 2024

40% of US cancer cases linked to lifestyle choices

Nearly 40% of cancer cases and 44% of cancer deaths in 2019 were due to modifiable risk factors, with cigarette smoking as the leading cause. This study highlights the potential to significantly reduce cancer burden through lifestyle changes.

14 Jul 2024

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

A new study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 cancer deaths in 2019) could be attributed to modifiable risk factors, including cigarette smoking, excess body weight, alcohol consumption, physical inactivity, diet, and infections.

11 Jul 2024

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells blood vessels in the liver start a "sleep timer" that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies.

11 Jul 2024

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Hepatocellular carcinoma (HCC) is a primary liver cancer predominantly arising from chronic liver diseases such as hepatitis B and C infections, alcohol abuse, and metabolic disorders.

2 Jul 2024

Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

Countries in Asia Pacific are unlikely to meet their commitment to eliminate hepatitis by 2030 unless they declare a public health emergency, as they did with COVID-19, a disease specialist suggested.

1 Jul 2024

Human milk banks improve infant health but can't fully replace mother's milk

Scientists investigate human milk banks and their impact on infant health, highlighting differences between donated and maternal milk in gut microbiota and development.

25 Jun 2024

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

A recent study in BMC Medicine found that type 2 diabetes significantly increases the risk of various cancers, with the risk being even higher in patients with diabetic retinopathy (DR).

2 Jun 2024

FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men

The federal government in 2020 and 2023 changed who it said could safely donate organs and blood, reducing the restrictions on men who have had sex with another man.

24 May 2024

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

Global HIV, viral hepatitis epidemics and sexually transmitted infections (STIs) continue to pose significant public health challenges, causing 2.5 million deaths each year, according to a new WHO report - Implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030.

22 May 2024

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years through a cooperative agreements research project grant, known as a U01 grant.

9 May 2024

50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives

The World Health Organization’s Expanded Programme on Immunization (EPI) has prevented 154 million deaths since 1974, significantly reducing global infant mortality and contributing 10.2 billion years of healthy life due to vaccinations.

7 May 2024

Hepatitis B

Overview

Hepatitis B Mechanisms

Hepatitis B Diagnosis

Hepatitis B Prevention

Feature Articles

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

Ratiometric fluorescent probes for measuring active albumin in liver disease patients

Tenofovir amibufenamide does not alter lipid levels in patients with chronic hepatitis B

Evaluating the effectiveness of GAAD for early detection of hepatocellular carcinoma

Cardiovascular risks of COVID-19 antivirals

Global and Local Efforts to Take Action Against Hepatitis

State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021

Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma

40% of US cancer cases linked to lifestyle choices

Study: 40% of cancer cases in the U.S. attributable to modifiable risk factors

Liver's defense mechanism hinders immunity in chronic hepatitis B, study reveals

Advancements in immunotherapy for hepatocellular carcinoma offer hope to patients

Asia Pacific faces hepatitis crisis: Urgent action needed to meet WHO targets

Human milk banks improve infant health but can't fully replace mother's milk

Type 2 diabetes linked to higher cancer risk, especially with diabetic retinopathy, study finds

FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men

WHO report highlights rising STI rates and insufficient progress in HIV and hepatitis control

UT Health San Antonio leads effort for developing oral vaccine against chlamydia

50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis B

Overview

Feature Articles

Hepatitis B Treatment

Hepatitis B Prognosis

Hepatitis B Symptoms

Hepatitis B Immunization

Hepatitis B and Hepatitis D

Closed Circular DNA and Hepatitis B Infection

Hepatitis B Structure: Capsid Flexibility and Function

Is Hepatitis Preventable?

Latest Hepatitis B News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in